Aarhus Universitet

Advanced Cardiac Imaging and Metabolic Assessment

The institution demonstrates substantial expertise in developing and applying sophisticated magnetic resonance imaging techniques for cardiovascular evaluation. Research initiatives focus on utilizing hyperpolarized MRI to assess cardiac metabolism and function in various patient populations, including those with heart failure, atrial fibrillation, and individuals undergoing cardiac procedures. These non-invasive imaging approaches enable real-time visualization of myocardial metabolism and provide insights into cardiac energetics.

  • Hyperpolarized Carbon-13 Pyruvate MRI for Cardiac Metabolic Imaging
  • Cardiac Function Assessment in Atrial Fibrillation and Heart Failure
  • Metabolic Evaluation in Patients Undergoing Cardiac Ablation
  • Myocardial Perfusion and Tissue Characterization

The research extends to examining cardiac remodeling and metabolic changes following interventions such as catheter ablation, with particular attention to understanding the relationship between cardiac structure, function, and metabolic activity in diverse cardiovascular conditions.

Renal Pathophysiology and Kidney Disease

Significant research efforts are directed toward understanding kidney function and disease through advanced imaging methodologies. The institution investigates renal metabolism and perfusion using hyperpolarized MRI techniques in patients with various kidney conditions, including chronic kidney disease, diabetic nephropathy, and autosomal dominant polycystic kidney disease. These studies aim to elucidate metabolic alterations and functional changes in diseased kidneys.

  • Metabolic Imaging in Chronic Kidney Disease and Diabetic Nephropathy
  • Renal Function Assessment in Polycystic Kidney Disease
  • Kidney Perfusion and Oxygenation Studies
  • Non-invasive Biomarkers for Renal Disease Progression

Research activities encompass the development of novel imaging biomarkers to detect early kidney dysfunction and monitor disease progression, with applications in both diabetic complications and genetic kidney disorders.

Hepatic Metabolism and Liver Disease

The institution maintains an active research portfolio examining liver metabolism and function in health and disease. Investigations utilize advanced metabolic imaging to study hepatic glucose metabolism, lipid metabolism, and overall liver function in conditions such as non-alcoholic fatty liver disease and type 2 diabetes. The research aims to characterize metabolic dysregulation in liver pathology and identify potential therapeutic targets.

  • Hepatic Glucose and Pyruvate Metabolism Assessment
  • Metabolic Profiling in Non-Alcoholic Fatty Liver Disease
  • Liver Function in Diabetic Patients
  • Non-invasive Liver Metabolic Imaging

These studies contribute to understanding the complex interplay between hepatic metabolic pathways and systemic metabolic disorders, particularly in the context of diabetes and obesity-related liver conditions.

Metabolic Disorders and Diabetes Research

Comprehensive research programs address metabolic dysfunction across multiple organ systems in patients with diabetes mellitus and related metabolic conditions. The institution investigates how diabetes affects cardiac, renal, and hepatic metabolism using advanced imaging technologies. Studies examine the metabolic consequences of type 1 diabetes and type 2 diabetes on various organs, seeking to identify early markers of organ dysfunction.

  • Multi-organ Metabolic Assessment in Diabetic Patients
  • Cardiac and Renal Complications of Diabetes
  • Metabolic Imaging in Type 1 and Type 2 Diabetes
  • Diabetic Cardiomyopathy and Nephropathy Evaluation

Research efforts focus on characterizing the metabolic alterations that precede clinical manifestations of diabetic complications, with potential implications for early intervention strategies and monitoring therapeutic responses.

Oncological Metabolic Imaging

The institution pursues research in cancer metabolism through the application of hyperpolarized MRI for tumor characterization and treatment monitoring. Studies investigate metabolic profiles of various malignancies, including prostate cancer, breast cancer, and brain tumors. The research aims to develop non-invasive methods for assessing tumor metabolism and evaluating responses to cancer therapies.

  • Metabolic Imaging in Prostate and Breast Cancer
  • Brain Tumor Metabolic Characterization
  • Treatment Response Assessment Using Metabolic Imaging
  • Tumor Perfusion and Metabolic Activity Evaluation

These investigations seek to enhance understanding of cancer cell metabolism and develop imaging biomarkers that can guide treatment decisions and predict therapeutic outcomes in oncology patients.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Metabolic Impairment in ALS and TIA Patients Using Hyperpolarized Pyruvate MRI

    Recruiting

    2 1 1
    Investigated drugs:
    Denmark
  • Study on Chronic Kidney Disease and Polycystic Kidney Disease Using Pyruvic Acid and MRI for Patients with These Conditions

    Recruiting

    2 1 1
    Investigated drugs:
    Denmark
  • Study on Early Detection of Liver Cancer Using Hyperpolarized Pyruvate MRI for Patients with Primary Liver Cancer

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study on Mitomycin and BCG for Patients with Recurrent Non-Muscle Invasive Bladder Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Denmark Iceland Norway Sweden
  • Study on the Use of Hyperpolarized Pyruvate for MRI Scans in Patients with Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated drugs:
    Denmark
  • MRI Study with Hyperpolarized Pyruvate for Patients with Glioblastoma

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark